Wolfgang Miesbach/LinkedIn
Apr 19, 2026, 13:42
Wolfgang Miesbach: Key Insights on Hemophilia Care at WFH 2026 Pre-Congress Workshop
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Great start to the pre‑congress workshop ‘Safety, Efficacy, and Access in Hemophilia and Rare Bleeding Disorders’ at WFH 2026 in Kuala Lumpur this morning, expertly chaired by Radoslaw (Radek) Kaczmarek.
Even though I missed the most, I caught excellent talks and discussion on the last part about haemostatic agents, prophylaxis, and their impact on everyday practice.
The session on how and when to start which type of prophylaxis – with great presentations by Steve Pipe and Manuel Carcao – will strongly inform day‑to‑day decisions and individualized care.”
Stay updated with Hemostasis Today.
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome
-
Sep 8, 2026, 08:39ASH-a-Palooza – Exploring What’s Next in Hematology
-
Sep 8, 2026, 08:23Khaled Musallam: A Masterclass on Thalassemia Care in the MENA Region